PHASE-II EVALUATION OF BISANTRENE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CARCINOMA

被引：0
|
作者：
FELD, R
EVANS, WK
SHEPHERD, FA
DEBOER, G
OTTEMA, B
机构：
[1] TORONTO GEN HOSP,DEPT MED,TORONTO M5G 1L7,ONTARIO,CANADA
[2] UNIV TORONTO,PRINCESS MARGARET HOSP,ONTARIO CANC INST,DEPT BIOSTAT,TORONTO M4X 1K9,ONTARIO,CANADA
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [21] BISANTRENE IN NON-SMALL CELL LUNG-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIA GROUP-B
    GREEN, MR
    VOSIKA, G
    PROPERT, KJ
    WARE, JH
    COMIS, R
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 539 - 540
  • [22] PHASE-II TRIAL OF ANAXIRONE IN ADVANCED NON-SMALL CELL LUNG-CANCER
    FIEBIG, HH
    HENSS, H
    ARNOLD, H
    VONBULTZINGSLOWEN, F
    KLEE, M
    QUEISSER, W
    PEUKERT, M
    CANCER TREATMENT REPORTS, 1987, 71 (05): : 539 - 540
  • [23] PHASE-II TRIAL OF AMINOTHIADIAZOLE IN ADVANCED NON-SMALL CELL LUNG-CANCER
    SHEVRIN, DH
    MCGUIRE, WP
    LANZOTTI, V
    KRAUSS, S
    BLOUGH, R
    COBLEIGH, M
    JOHNSON, C
    LAD, T
    KUKLA, L
    CANCER TREATMENT REPORTS, 1986, 70 (03): : 417 - 418
  • [24] PHASE-II STUDY OF PIRARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    BERTHAUD, P
    LECHEVALIER, T
    BERILLE, J
    HERAIT, P
    BALDEYROU, P
    TURSZ, T
    ARRIAGADA, R
    SPIELMANN, M
    HAYAT, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (09): : 1337 - 1338
  • [25] PHASE-II STUDY OF PIRARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    BERTHAUD, P
    LECHEVALIER, T
    BERILLE, J
    HERAIT, P
    BALDEYROU, P
    TURSZ, T
    ARRIAGADA, R
    SPIELMANN, M
    HAYAT, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (10): : 1507 - 1508
  • [26] PHASE-II TRIAL OF BISANTRENE FOR UNRESECTABLE NON-SMALL CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY
    MCGUIRE, WP
    BLOUGH, RR
    COBLEIGH, MA
    JOHNSON, CM
    KUKLA, LJ
    LAD, TE
    LANZOTTI, VJ
    STIFF, PJ
    ZAWILA, P
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 841 - 842
  • [27] PHASE-II STUDIES OF PCNU AND BISANTRENE IN ADVANCED RENAL-CELL CARCINOMA
    ELSON, PJ
    EARHART, RH
    KVOLS, LK
    SPIEGEL, R
    KELLER, AM
    KIES, MS
    DAVIS, TE
    STEVENS, C
    GUMAS, L
    TRUMP, DL
    CANCER TREATMENT REPORTS, 1987, 71 (03): : 331 - 332
  • [28] RESULTS OF A PHASE-II PROTOCOL FOR EVALUATION OF NEW CHEMOTHERAPEUTIC REGIMENS IN PATIENTS WITH INOPERABLE NON-SMALL CELL LUNG-CARCINOMA (EST-2575, GENERATION-I)
    CREECH, RH
    MEHTA, CR
    COHEN, M
    DONAVAN, M
    SPONZO, R
    MASON, BA
    SKEEL, RT
    AHMED, F
    CREAVEN, PJ
    LERNER, HJ
    FOELSCH, E
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 431 - 438
  • [29] PHASE-II TRIAL OF BISANTRENE IN ADVANCED COLORECTAL-CARCINOMA
    AHMED, T
    KEMENY, NE
    MICHAELSON, RA
    HARPER, HD
    CANCER TREATMENT REPORTS, 1983, 67 (03): : 307 - 308
  • [30] Psorinum Therapy in Treating Patients With Advanced Non-small Cell Lung Carcinoma (NSCLC): A Phase-II Single Arm Clinical Trial
    Chatterjee, A.
    Biswas, J.
    Bhattacharya, S.
    Chakraborty, A.
    Mukherjee, R.
    Bhakta, R.
    Das, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S532 - S532
12345